ZSCAN29 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.710000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.328400E-01
Normal-vs-Stage2
8.161500E-02
Normal-vs-Stage3
1.777200E-01
Normal-vs-Stage4
5.819800E-01
Stage1-vs-Stage2
1.641830E-01
Stage1-vs-Stage3
1.736640E-03
Stage1-vs-Stage4
7.712600E-01
Stage2-vs-Stage3
7.073800E-02
Stage2-vs-Stage4
5.483200E-01
Stage3-vs-Stage4
2.344400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.598000E-02
Normal-vs-AfricanAmerican
3.154600E-01
Normal-vs-Asian
6.118100E-02
Caucasian-vs-AfricanAmerican
7.945800E-01
Caucasian-vs-Asian
1.407230E-01
AfricanAmerican-vs-Asian
2.611800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.223800E-02
Normal-vs-Female
1.198770E-01
Male-vs-Female
1.865020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.196400E-01
Normal-vs-Age(41-60Yrs)
1.257560E-01
Normal-vs-Age(61-80Yrs)
7.148500E-02
Normal-vs-Age(81-100Yrs)
1.105230E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.722400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.238200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.894370E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.019160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.494200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.402800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.091700E-02
Normal-vs-Daily Drinker
7.326100E-02
Normal-vs-Weekly Drinker
3.480400E-01
Normal-vs-Occasional Drinker
3.670800E-01
Normal-vs-Social Drinker
3.158000E-01
Non Drinker-vs-Daily Drinker
9.417800E-01
Non Drinker-vs-Weekly Drinker
4.796400E-01
Non Drinker-vs-Occasional Drinker
5.140800E-01
Non Drinker-vs-Social Drinker
6.896100E-02
Daily Drinker-vs-Weekly Drinker
4.855400E-01
Daily Drinker-vs-Occasional Drinker
6.272400E-01
Daily Drinker-vs-Social Drinker
1.344810E-01
Weekly Drinker-vs-Occasional Drinker
7.198200E-01
Weekly Drinker-vs-Social Drinker
6.462400E-01
Occasional Drinker-vs-Social Drinker
2.091000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.558300E-02
Normal-vs-Grade 2
2.584500E-03
Normal-vs-Grade 3
3.503600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.937400E-01
Grade 1-vs-Grade 3
3.451800E-01
Grade 1-vs-Grade 4
2.558300E-02
Grade 2-vs-Grade 3
3.686800E-01
Grade 2-vs-Grade 4
2.584500E-03
Grade 3-vs-Grade 4
3.503600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.863900E-02
Normal-vs-NonDiabetic
7.425600E-02
Diabetic-vs-NonDiabetic
1.067380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.088000E-01
Normal-vs-NoPancreatitis
6.397900E-02
Pancreatitis-vs-NoPancreatitis
7.256800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.080300E-02
Normal-vs-N1
8.607900E-02
N0-vs-N1
5.023000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.651000E-01
Normal-vs-TP53-NonMutant
3.589800E-01
TP53-Mutant-vs-TP53-NonMutant
7.450200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
